AP2001002113A0 - Neuroimmunophilins for selective neuronal radioprotection. - Google Patents

Neuroimmunophilins for selective neuronal radioprotection.

Info

Publication number
AP2001002113A0
AP2001002113A0 APAP/P/2001/002113A AP2001002113A AP2001002113A0 AP 2001002113 A0 AP2001002113 A0 AP 2001002113A0 AP 2001002113 A AP2001002113 A AP 2001002113A AP 2001002113 A0 AP2001002113 A0 AP 2001002113A0
Authority
AP
ARIPO
Prior art keywords
neuroimmunophilins
radioprotection
selective neuronal
ionizing radiation
selectively protecting
Prior art date
Application number
APAP/P/2001/002113A
Other languages
English (en)
Inventor
Marcus Keep
Eskil Elmer
Original Assignee
Marcus Keep
Eskil Elmer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marcus Keep, Eskil Elmer filed Critical Marcus Keep
Publication of AP2001002113A0 publication Critical patent/AP2001002113A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
APAP/P/2001/002113A 1998-09-23 1998-09-23 Neuroimmunophilins for selective neuronal radioprotection. AP2001002113A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/020040 WO2000016794A1 (fr) 1998-09-23 1998-09-23 Neuro-immunophillines pour radioprotection neuronale selective

Publications (1)

Publication Number Publication Date
AP2001002113A0 true AP2001002113A0 (en) 2001-06-30

Family

ID=22267931

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/2001/002113A AP2001002113A0 (en) 1998-09-23 1998-09-23 Neuroimmunophilins for selective neuronal radioprotection.

Country Status (10)

Country Link
EP (1) EP1115412A4 (fr)
JP (1) JP2002526453A (fr)
CN (1) CN1322136A (fr)
AP (1) AP2001002113A0 (fr)
AU (1) AU766095B2 (fr)
BR (1) BR9816047A (fr)
CA (1) CA2345378A1 (fr)
HK (1) HK1040617A1 (fr)
IL (1) IL142120A0 (fr)
WO (1) WO2000016794A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE314084T1 (de) 2000-10-31 2006-01-15 Pharma Mar Sa Kahalalid f formulierung
WO2005103255A1 (fr) * 2004-03-25 2005-11-03 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Recepteur formylpeptide (fpr) utilise en tant que cible pour une therapie anti-gliome malin
US11745029B2 (en) 2018-05-30 2023-09-05 Zap Surgical Systems, Inc. Radiosurgical neuromodulation close to critical structures

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE520730C2 (sv) * 1995-01-20 2003-08-19 Eskil Elmer Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel
JP3089350B2 (ja) * 1995-11-20 2000-09-18 ギルフォード ファーマシューティカルズ インコーポレイテッド シクロフィリンロタマーゼ活性の阻害剤

Also Published As

Publication number Publication date
CN1322136A (zh) 2001-11-14
CA2345378A1 (fr) 2000-03-30
AU9508198A (en) 2000-04-10
IL142120A0 (en) 2002-03-10
AU766095B2 (en) 2003-10-09
HK1040617A1 (zh) 2002-06-21
BR9816047A (pt) 2003-01-07
JP2002526453A (ja) 2002-08-20
EP1115412A4 (fr) 2004-12-15
WO2000016794A1 (fr) 2000-03-30
EP1115412A1 (fr) 2001-07-18

Similar Documents

Publication Publication Date Title
EP0859639A4 (fr) Procedes de traitement de cancers et de la restenose a l'aide de p21
DE69530272D1 (de) Implantierbare Vorrichtung mit Schutzmitteln gegen elektromagnetische Störungen
HU9601870D0 (en) Cryptographic system and method with key escrow feature
AU7686994A (en) Investment fund management method and system
DE69227109D1 (de) Durchsichtiges, uv absorbierendes sonnenschutzmittel und verfahren zu dessen herstellung
GB9405741D0 (en) Semiconductor laser array device semiconductor laser device and production methods therefor
GB2352680B (en) Anti counterfeit structure of passport and method for manufacturing the same
HK1040053B (zh) 稠合吡咯並咔唑在預防/治療耳蝸毛細胞和耳蝸神經元損傷的用途
ZA200003240B (en) Connector for use in cathodic protection and method of use.
ZA94392B (en) Internal radiation damage
GB2345361B (en) Copy protection system and method
AU6549198A (en) System and method for multi-level memory domain protection
EP0675543A3 (fr) Dispositif semi-conducteur comprenant des moyens de protection et procédé de fabrication associé.
EP0640985A3 (fr) Système d'alimentation négative distribuée pour grilles.
WO1998018440A3 (fr) Utilisation des inhibiteurs de l'activite de l'acide retinoique pour traiter les peaux sensibles
AU5173199A (en) Method and device for authenticating with symmetrical algorithm
FR2676576B1 (fr) Casque de protection et d'ecoute a audition orientee.
AP2001002113A0 (en) Neuroimmunophilins for selective neuronal radioprotection.
GB2317111B (en) Irradiation protection method
GB9408129D0 (en) Water management and treatment systems
AU5819996A (en) Topically applicable agents for treating and preventing alopecia
DE69421781D1 (de) Garnitur zum Verbinden eines Energiekabels und damit ausgerüstetes Energiekabel
IL115020A0 (en) Methods for inhibiting neuronal damage
AU3177893A (en) Method for diagnosing and treating cancer
NO931347D0 (no) Piperazin-derivat, fremgangsmaate for fremstilling, samt anvendelse